Obesity: Teaching an old drug new tricks - Amlexanox targets inflammation to improve metabolic dysfunction

Nature Reviews Endocrinology

Volumn 9, Issue 4, 2013, Pages 185-

  Koch, Linda ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMLEXANOX; I KAPPA B KINASE EPSILON;

ASTHMA; BODY WEIGHT; EXPERIMENTAL MOUSE; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; METABOLIC DISORDER; MOUTH ULCER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL;

EID: 84875443579     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.42     Document Type: Note

References (1)

1. Reilly, S. M. et al. An inhibitor of the protein kinases TBK1 and IKK-ε improves obesity-related metabolic dysfunctions in mice. Nat. Med. doi:10.1038/nm.3082